期刊文献+

幽门螺杆菌“检测和治疗”策略对未经调查消化不良患者处理的安全性评估 被引量:11

Safety of Helicobacter pylori ‘test-and-treat’ strategies for the management of uninvestigated dyspepsia
原文传递
导出
摘要 目的评价幽门螺杆菌(Hp)“检测和治疗”及“检测和内镜检查”策略在上海地区未经调查的消化不良患者处理中应用的安全性。方法回顾性调查2002-2003年在上海仁济医院内镜中心接受胃镜检查的上海本地区消化不良患者中胃、食管、十二指肠恶性肿瘤的检出率、报警症状及Hp感染情况。结果14101例消化不良患者中,检出胃、食管、十二指肠恶性肿瘤者202例(143%),其中胃癌162例(115%)、胃恶性淋巴瘤4例、食管癌35例(025%)和十二指肠癌1例。恶性肿瘤患者中Hp感染率为490%,报警症状发生率为535%。45岁以下者中检出恶性肿瘤18例(046%),均为胃癌,报警症状发生率为278%,Hp感染率为722%。如在上述无报警症状、年龄小于45岁患者中采用Hp“检测和治疗”策略,则将漏诊胃癌13例(722%),如采用Hp“检测和内镜检查”策略,则将漏诊胃癌3例(167%)。结论Hp“检测和治疗”及“检测和内镜检查”策略均不适用于上海地区未经调查消化不良患者的处理。对多数上海地区成人消化不良患者,即时内镜检查将是初始处理的首选策略。 Objective To verify the safety of Helicobacter pylori (Hp)‘test-and-treat’ and ‘test-and-endoscopy’strategies for management of uninvestigated dyspepsia in Shanghai patients. Methods ~14 101 consecutive patients presented with dyspepsia receiving endoscopy during Oct. 2002 to Dec. 2003 were retrospectively analyzed in this study. The detective rate of esophageal or gastroduodenal malignancies and alarm symptoms were investigated and Hp status was assessed. Results Total 202(1.43%)malignancies were found, including gastric cancer in 162 (1.15%), malignant gastric lymphoma in 4, esophageal cancer in 35 (0.25%) and duodenal cancer in 1. Among those patients with malignancies, ninety-nine (49.0%) patients were infected with Hp and 108 (53.5%) presented with alarm symptoms. Eighteen patients (0.46%) under the age of 45 years were diagnosed as gastric cancer. Among these patients, 5 (27.8%) presented with alarm symptoms and 13 (72.2%) were infected with Hp . If the Hp ‘test-and-treat’strategy was used in dyspeptic patients under the age of 45 years without alarm symptoms in Shanghai region, then 13 cases (72.2%) of gastric cancer would be missed. If the Hp ‘test-and-endoscopy’strategy was applied, then 3 cases (16.7%) of gastric cancer would be missed. Conclusions Hp ‘test-and-treat’and ‘test-and-endoscopy’strategies are all not suitable for the management of uninvestigated dyspepsia in Shanghai patients. For most Shanghai adult dyspeptic patients, prompt endoscopy should be recommended as the first-line initial management option.
出处 《中华内科杂志》 CAS CSCD 北大核心 2005年第3期195-197,共3页 Chinese Journal of Internal Medicine
基金 上海市临床医学中心基金资助项目
关键词 治疗 患者 消化不良 内镜检查 胃癌 HP感染 处理 上海地区 症状 安全性评估 Dyspepsia Helicobacter pylori Stomach neoplasms test-and-treat
  • 相关文献

参考文献15

  • 1柯美云,罗金燕,许国铭.我国消化不良的诊治流程和指南[J].中华内科杂志,2000,39(10):717-718. 被引量:18
  • 2刘恩菊,项永兵,金凡,周淑贞,孙璐,方茹蓉,阮志贤,高立峰,高玉堂.上海市区恶性肿瘤发病趋势分析(1972~1999年)[J].肿瘤,2004,24(1):11-15. 被引量:134
  • 3Talley NJ, Silverstein MD, Agreus L, et al. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology, 1998, 114: 582-595.
  • 4McColl KE, Murray LS, Gillen D, et al. Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia. BMJ, 2002, 324: 999-1002.
  • 5Farkkila M, Sarna S, Valtonen V, et al. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients. Scand J Gastroenterol, 2004, 39: 327-335.
  • 6Chiba N, Veldhuyzen Van Zanten SJ, Escobedo S, et al. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia. Aliment Pharmacol Ther, 2004, 19: 349-358.
  • 7Talley NJ. Dyspepsia. Gastroenterology, 2003, 125: 1219-1226.
  • 8Moayyedi P. Helicobacter pylori test and treat strategy for young dyspeptic patients: new data. Gut, 2002, 50 Suppl 4: iv47-50.
  • 9Chey WD, Moayyedi P. Uninvestigated dyspepsia and non-ulcer dyspepsia-the use of endoscopy and the roles of Helicobacter pylori eradication and antisecretory therapy. Aliment Pharmacol Ther, 2004, 19 Suppl 1: 1-8.
  • 10Chiba N, Van Zanten SJ, Sinclair P, et al. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial. BMJ, 2002, 324: 1012-1016.

二级参考文献13

  • 1孙国桢.上海人口老龄化对医疗保障压力的对策研究[J].中国卫生资源,2001,4(2):86-88. 被引量:15
  • 2World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death, Vol 1[M]. WHO, Geneva 1977.
  • 3Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Descriptive epidemiology Vol IV[M]. IARC Scientific Publications, No 128, Lyon, 1994.
  • 4Yu H, Harris RE, Gao YT, et al. Comparative epidemiology of cancers of the colon, rectum, prostate and breast in Shanghai, China versus the United States[J]. Int J Epidemiol, 1991, 20:76.
  • 5Hulka BS. Epidemiologic analysis of breast and gynecologic cancers[J]. Progr[J]. Clin Blot Res, 1997, 396: 17.
  • 6Hsing AW, Devesa SS, Jin F, et al. Rising incidence of prostate cacer in Shanghai, China [letter][J]. Cancer Epidemiol Biomarkers Prey, 1998, 7 : 83.
  • 7Gao YT. Risk factors for lung cancer among nonsmokers with emphasis on lifesyle factors [J]. Lung cancer, 1996, 14 (suppl1) :39.
  • 8Zhong L, Goldberg MS, Gao YT, et al. A case-control study of lung cancer and environmental tobacco smoke among nonsmoking women living in Shanghai, China[J]. Cancer Causes & Control, 1999, 10(6):607.
  • 9Yuan JM, Ross RK, Chu XD, et al. Prediagnostic levels of serum 13-Cryptoxanthin and retinal predict smoking-related lung cancer risk in Shanghai, China[J]. Cancer epidemiology biomarker & Prevention, 2001, 10:767.
  • 10Zhong L, Goldberg MS, Gao YT, et al. A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China [J]. Epidemiology, 2001,12(6) :695.

共引文献150

同被引文献100

引证文献11

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部